| 查看: 467 | 回复: 1 | ||
| 本帖产生 1 个 LS-EPI ，点击这里进行查看 | ||
金鑫891木虫 (正式写手)
|
[求助]
求地拉罗司默克索引
|
|
|
求地拉罗司默克索引 CAS no：201530-41-8 |
回复此楼» 猜你喜欢
售SCI一区T0P文章，我:8.O.55.1.O54,科目全,可伽急
已经有4人回复
-
售SCI一区T0P文章，我:8.O55.1.O.54,科目全,可十急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.5.4,科目全,可+急
已经有5人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有23人回复
-
售SCI一区文章，我:8.O.55.1.O.54,科目齐全,可伽急
已经有22人回复
-
售SCI一区T0P文章，我:8.O55.1.O.54,科目全,可十急
已经有7人回复
-
售一区SCI文章T0P，我:8O.551.O54,科目全,可十急
已经有5人回复
-
售SCI一区文章，我:8O5.5.1.O5.4,科目全,可伽急
已经有8人回复
-
售SCI一区文章，我:8.O.55.1.O.54,科目齐全,可伽急
已经有14人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有11人回复
baiyuefei
版主 (文学泰斗)
风雪
- LS-EPI: 1647
- 应助: 4643 (副教授)
- 贵宾: 46.97
- 金币: 658873
- 散金: 11616
- 红花: 995
- 沙发: 81
- 帖子: 69659
- 在线: 13563小时
- 虫号: 676696
- 注册: 2008-12-18
- 性别: GG
- 专业: 合成药物化学
- 管辖: 有机交流
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
金鑫891: 金币+15 2013-07-29 07:49:22
oven1986: 检索EPI+1, 感谢积极应助。 2013-07-29 16:14:00
金鑫891: 金币+15 2013-07-29 07:49:22
oven1986: 检索EPI+1, 感谢积极应助。 2013-07-29 16:14:00
|
Title: Deferasirox CAS Registry Number: 201530-41-8 CAS Name: 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid Manufacturers' Codes: ICL-670; ICL-670A; CGP-72670 Trademarks: Exjade (Novartis) Molecular Formula: C21H15N3O4 Molecular Weight: 373.36 Percent Composition: C 67.56%, H 4.05%, N 11.25%, O 17.14% Literature References: Orally active tridentate iron chelator. Prepn: R. Lattmann, P. Acklin, WO 9749395; eidem, US 6465504 (1997, 2002 both to Novartis); U. Heinz et al., Angew. Chem. Int. Ed. 38, 2568 (1999). HPLC determn in plasma: M. C. Rouan et al., J. Chromatogr. B 755, 203 (2001). Iron complex formation study: S. Steinhauser et al., Eur. J. Inorg. Chem. 2004, 4177. Pharmacology: C. Hershko et al., Blood 97, 1115 (2001). Clinical pharmacokinetics: R. Galanello et al., J. Clin. Pharmacol. 43, 565 (2003). Clinical trial in thalassemia: E. Nisbet-Brown et al., Lancet 361, 1597 (2003). Review of structure activity: H. Nick et al., Curr. Med. Chem. 10, 1065-1076 (2003); of preclinical and clinical experience: M. D. Cappellini, Best Prac. Res. Clin. Haematol. 18, 289-298 (2005). Properties: Crystals from ethanol, mp 264-265°. Soly in water at 25° (mg/ml): 0.4 (pH 7.40). pKa1 4.57, pKa2 8.71, pKa3 10.56 (Nick). Also reported in H2O/DMSO (CDMSO = 0.20) as pKa1 4.61, pKa2 10.12, pKa3 12.08 (Steinhauser). Partition coefficient (octanol/water): 6.3 (pH 7.40). uv max (H2O/DMSO, pH < 2): 284 nm (e 1.5 ´ 104). Melting point: mp 264-265° pKa: pKa1 4.57, pKa2 8.71, pKa3 10.56 (Nick); Also reported in H2O/DMSO (CDMSO = 0.20) as pKa1 4.61, pKa2 10.12, pKa3 12.08 (Steinhauser) Log P: Partition coefficient (octanol/water): 6.3 (pH 7.40) Absorption maximum: uv max (H2O/DMSO, pH < 2): 284 nm (e 1.5 ´ 104) Therap-Cat: Chelating agent (iron). Keywords: Chelating Agent. |
2楼2013-07-28 23:26:02
